The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
Open accessAbstract
BACKGROUND: S100β protein is expressed constitutively by brain astrocytes. Elevated S100β levels in cerebrospinal fluid and serum reported after head trauma, subarachnoid hemorrhage, and stroke were correlated with the extent of brain damage. Because elevated serum S100β also was shown to indicate blood‐brain barrier (BBB) dysfunction in the absence of apparent brain injury, it remains unclear whether elevation of serum levels of S100β reflect BBB dysfunction, parenchymal damage, or both. METHODS: The authors conducted a prospective study of serum S100β levels in six patients who underwent hyperosmotic BBB disruption (BBBD) with intraarterial chemotherapy for primary central nervous system lymphoma. In addition, 53 serum S100β samples were measured in 51 patients who had a variety of primary or metastatic brain lesions at the time of neuroimaging. RESULTS: S100β was correlated directly with the degree of clinical and radiologic signs of BBBD in patients who were enrolled in the hyperosmotic study. In patients with neoplastic brain lesions, gadolinium enhancement on a magnetic resonance image was correlated with elevated S100β levels (n = 45 patients; 0.16 ± 0.1 μg/L; mean ± standard error of the mean) versus nonenhancing scans (n = 8 patients; 0.069 ± 0.04 μg/L). Primary brain tumors (n = 8 patients; 0.12 ± 0.08) or central nervous system metastases also presented with elevated serum S100β levels (n = 27 patients; 0.14 ± 0.34). Tumor volume was correlated with serum S100β levels only in patients with vestibular schwannoma (n = 6 patients; 0.13 ± 0.10 μg/L) but not in patients with other brain lesions. CONCLUSIONS: S100β was correlated directly with the extent and temporal sequence of hyperosmotic BBBD, further suggesting that S100β is a marker of BBB function. Elevated S100β levels may indicate the presence of radiologically detectable BBB leakage. Larger prospective studies may better determine the true specificity of S100β as a marker for BBB function and as an early detection or follow‐up marker of brain tumors. Cancer 2003;97:2806–13. © 2003 American Cancer Society. DOI 10.1002/cncr.11409
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The S100 family of EF-hand calcium-binding proteins: functions and pathology
SCHAFER, B. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)10020-7 · Cited by 999
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
The S100 family of EF-hand calcium-binding proteins: functions and pathology
Schäfer, B. W., & Heizmann, C. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80167-8 · Cited by 682
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
Chen, Z.-L., & Strickland, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80483-3 · Cited by 632
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
KrolI, R. A., Neuwelt, E. A., & Neuwelt, E. A. (1998) · Neurosurgery · doi:10.1097/00006123-199805000-00082 · Cited by 581
Persson, L., Hårdemark, H. G., Gustafsson, J., Rundström, G., Mendel-Hartvig, I., Esscher, T., & Påhlman, S. (1987) · Stroke · doi:10.1161/01.str.18.5.911 · Cited by 486
Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997) · Stroke · doi:10.1161/01.str.28.10.1956 · Cited by 456
Herrmann, M., Vos, P., Wunderlich, M. T., de Bruijn, C. H. M. M., & Lamers, K. J. B. (2000) · Stroke · doi:10.1161/01.str.31.11.2670 · Cited by 400
Neuwelt, E. A., Goldman, D. L., Dahlborg, S. A., Crossen, J., Ramsey, F., Roman-Goldstein, S., Braziel, R., & Dana, B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1580 · Cited by 380
Serum S-100β as a possible marker of blood–brain barrier disruption
Kapural, M., Krizanac-Bengez, L., Barnett, G., Perl, J., Masaryk, T., Apollo, D., Rasmussen, P., Mayberg, M. R., & Janigro, D. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02586-6 · Cited by 284
Self-citation
Cited by
Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
The influence of neuroinflammation in Autism Spectrum Disorder
Matta, S. M., Hill-Yardin, E. L., & Crack, P. J. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.037 · Cited by 416
Thelin, E. P., Nelson, D. W., & Bellander, B.-M. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-016-3046-3 · Cited by 317
Consequences of Repeated Blood-Brain Barrier Disruption in Football Players
Marchi, N., Bazarian, J. J., Puvenna, V., Janigro, M., Ghosh, C., Zhong, J., Zhu, T., Blackman, E., Stewart, D., Ellis, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056805 · Cited by 295
Self-citationBrandes, A. A., Carpentier, A. F., Kesari, S., Sepulveda-Sanchez, J. M., Wheeler, H. R., Chinot, O., Cher, L., Steinbach, J. P., Capper, D., Specenier, P., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now009 · Cited by 273
Friedman, A., Kaufer, D., & Heinemann, U. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.005 · Cited by 270
Thelin, E. P., Zeiler, F. A., Ercole, A., Mondello, S., Büki, A., Bellander, B.-M., Helmy, A., Menon, D. K., & Nelson, D. W. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00300 · Cited by 260
Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Saenger, A. K., & Christenson, R. H. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133801 · Cited by 252
Mazzone, P., Tierney, W., Hossain, M., Puvenna, V., Janigro, D., & Cucullo, L. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7124111 · Cited by 183
Self-citationSerum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
Marchi, N., Granata, T., Freri, E., Ciusani, E., Ragona, F., Puvenna, V., Teng, Q., Alexopolous, A., & Janigro, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018200 · Cited by 150
Self-citation
Metadata
- Authors
- Kanner, A. A., Marchi, N., Fazio, V., Mayberg, M. R., Koltz, M. T., Siomin, V., Stevens, G. H. J., Masaryk, T., Ayumar, B., Vogelbaum, M. A., Barnett, G. H., & Janigro, D.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2003-05-19
- Volume
- 97
- Issue
- 11
- Pages
- 2806-2813
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2049278300
- Cited by
- 269
- References
- 26
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.